https://scholars.lib.ntu.edu.tw/handle/123456789/568650
標題: | How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? | 作者: | Amarapurkar D.N. Hashimoto E. Lesmana L.A. Sollano J.D. PEI-JER CHEN Goh K.-L. |
關鍵字: | Fatty liver disease; Non-alcoholic | 公開日期: | 2007 | 出版社: | Blackwell Publishing | 卷: | 22 | 期: | 6 | 起(迄)頁: | 788-793 | 來源出版物: | Journal of Gastroenterology and Hepatology (Australia) | 摘要: | Risk factors for development of non-alcoholic steatohepatitis include obesity, especially central adiposity, glucose intolerance or type 2 diabetes mellitus (T2DM), and dyslipidemia. Non-alcoholic fatty liver disease (NAFLD) is now considered a manifestation of metabolic syndrome. During the last two decades, NAFLD has become the most common chronic liver disease in North America and Europe, but until recently was thought to be uncommon (perhaps due to the lack of study) in Asia. Fatty liver can be identified on imaging modalities (ultrasonography, computed tomography scans, and magnetic resonance imaging) with high sensitivity, but steatohepatitis and fibrosis cannot be distinguished. Thus, an inherent drawback in studying the epidemiology of NAFLD is the lack of definitive laboratory tests, no uniform definition - with different studies using cut-off values of alcohol consumption from <20 g/week to 210 g/week, and case selections where biopsy was used for definition. In studies outside the region, the prevalence of NAFLD varies from 16% to 42% by imaging, and 15-39% of liver biopsies. The major risk factors for NAFLD, central obesity, T2DM, dyslipidemia, and metabolic syndrome, are now widely prevalent and are increasing geometrically in the Asia-Pacific region. It is therefore not surprising that NAFLD is common in this region. Estimates of current prevalence range from 5% to 30%, depending on the population studied. Central obesity, diabetes, and metabolic syndrome are the major risk factors. To date, however, data on the natural history and impact of NAFLD causing serious significant chronic liver disease are lacking and there is a need for prospective, cooperative studies. ? 2007 The Authors. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84984562986&doi=10.1111%2fj.1440-1746.2007.05042.x&partnerID=40&md5=1dffd004675398406df5d8f2d5d8838f https://scholars.lib.ntu.edu.tw/handle/123456789/568650 |
ISSN: | 0815-9319 | DOI: | 10.1111/j.1440-1746.2007.05042.x | SDG/關鍵字: | glucose; abdominal radiography; alcohol consumption; Asia; China; chronic liver disease; disease association; dyslipidemia; glucose blood level; health survey; high risk population; human; hyperinsulinemia; India; Indonesia; insulin resistance; Japan; Korea; liver biopsy; Malaysia; metabolic syndrome X; non insulin dependent diabetes mellitus; nonalcoholic fatty liver; obesity; prevalence; priority journal; review; risk factor; Singapore; Sri Lanka; statistical analysis; statistical significance |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。